NETs also activate a series of TLR9-dependent signaling pathways, such as the MAP kinase pathway and NF-κB pathway, in cancer cells by releasing high mobility group box 1 (HMGB1), thus promoting cell proliferation, adhesion, migration, and invasion [189]. Here, TLR9 is linked to cancer.